Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 127 Records) |
Query Trace: Pancreatic Neoplasms and KRAS[original query] |
---|
Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancer. Oncogene 2022 Jun . Datta Jashodeep, Bianchi Anna, De Castro Silva Iago, Deshpande Nilesh U, Cao Long Long, Mehra Siddharth, Singh Samara, Rafie Christine, Sun Xiaodian, Chen Xi, Dai Xizi, Colaprico Antonio, Sharma Prateek, Dosch Austin R, Pillai Asha, Hosein Peter J, Nagathihalli Nagaraj S, Komanduri Krishna V, Wilson Julie M, Ban Yuguang, Merchant Nipun |
KRAS and NOTCH1/2 Mutations are Associated With Pathologic and Clinical Outcomes in Localized Pancreatic Cancer Treated With Neoadjuvant Chemotherapy and Stereotactic Body Radiotherapy Followed by Surgical Exploration. International journal of radiation oncology, biology, physics 2021 Nov 111 (3S): e70. Reddy A V, Hill C, Sehgal S, Ding D, Zheng L, He J, Herman J M, Meyer J J, Narang |
The molecular landscape of pancreatobiliary cancers for novel targeted therapies from real-world genomic profiling. Journal of the National Cancer Institute 2022 May . Umemoto Kumiko, Yamamoto Hiroyuki, Oikawa Ritsuko, Takeda Hiroyuki, Doi Ayako, Horie Yoshiki, Arai Hiroyuki, Ogura Takashi, Mizukami Takuro, Izawa Naoki, Moore Jay A, Sokol Ethan S, Sunakawa |
Analysis of KRAS Mutation Subtype in Tissue DNA and Cell-Free DNA Using Droplet Digital PCR and the Function of Cell-Free DNA as a Recurrence Predictive Marker in Pancreatic Cancer. Biomedicines 2021 Nov 9 (11): . Jun Eunsung, Koo Bonhan, Kim Eo Jin, Hwang Dae Wook, Lee Jae Hoon, Song Ki Byung, Lee Woohyung, Park Yejong, Hong Sarang, Shin Yong, Kim Song Che |
Pancreatic Cancer-Related Mutational Burden Is Not Increased in a Patient Cohort With Clinically Severe Chronic Pancreatitis. Clinical and translational gastroenterology 2021 11 12 (11): e00431. Cowan Robert W, Pratt Erica D, Kang Jin Muk, Zhao Jun, Wilhelm Joshua J, Abdulla Muhamad, Qiao Edmund M, Brennan Luke P, Ulintz Peter J, Bellin Melena D, Rhim Andrew |
Optimal value of CA19-9 determined by KRAS-mutated circulating tumor DNA contributes to the prediction of prognosis in pancreatic cancer patients. Scientific reports 2021 Oct 11 (1): 20797. Watanabe Fumiaki, Suzuki Koichi, Tamaki Sawako, Abe Iku, Endo Yuhei, Takayama Yuji, Ishikawa Hideki, Kakizawa Nao, Saito Masaaki, Futsuhara Kazushige, Noda Hiroshi, Konishi Fumio, Rikiyama Toshi |
Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer. BioMed research international 2021 10 2021 9949272. Ma Zuyi, Li Zhenchong, Ma Zuguang, Zhou Zixuan, Zhuang Hongkai, Liu Chunsheng, Huang Bowen, Zou Yiping, Zheng Zehao, Yang LinLing, Gong Yuanfeng, Huang Shanzhou, Zhou Qi, Zhang Chuanzhao, Hou Baoh |
Genomic alterations in tumor tissue and ctDNA from Chinese pancreatic cancer patients. American journal of cancer research 2021 10 11 (9): 4551-4567. Xiong Anwen, Ma Ning, Wei Guo, Li Chunhua, Li Kainan, Wang B |
Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma. Frontiers in oncology 2022 12 926260. Guan Shasha, Deng Guochao, Sun Jingjie, Han Quanli, Lv Yao, Xue Tianhui, Ding Lijuan, Yang Tongxin, Qian Niansong, Dai Guangh |
Analysis of genomic alterations in cancer associated human pancreatic stellate cells. Scientific reports 2022 8 12 (1): 13532. Böker Viktoria, Häußler Johanna, Baumann Jenny, Sunami Yoshiaki, Trojanowicz Bogusz, Harwardt Bernadette, Hammje Kathrin, von Auw Nadine, Erkan Mert, Krohn Knut, Kleeff Jö |
Molecular Landscape and Prognostic Biomarker Analysis of Advanced Pancreatic Cancer and Predictors of Treatment Efficacy of AG Chemotherapy. Frontiers in oncology 2022 12 844527. Du Juan, Qiu Xin, Lu Changchang, Zhu Yahui, Kong Weiwei, Xu Mian, Zhang Xin, Tang Min, Chen Jun, Li Qi, Li Aimei, He Jian, Gu Qing, Wang Lei, Qiu Yudong, Liu Baor |
Is Biannual Surveillance for Pancreatic Cancer Sufficient in Individuals With Genetic Syndromes or Familial Pancreatic Cancer? Journal of the National Comprehensive Cancer Network : JNCCN 2022 6 20 (6): 663-673.e12. Wang Yifan, Cuggia Adeline, Chen Yen-I, Parent Josée, Stanek Agatha, Denroche Robert E, Zhang Amy, Grant Robert C, Domecq Céline, Golesworthy Bryn, Shwaartz Chaya, Borgida Ayelet, Holter Spring, Wilson Julie M, Chong George, O'Kane Grainne M, Knox Jennifer J, Fischer Sandra E, Gallinger Steven, Gao Zu-Hua, Foulkes William D, Waschke Kevin A, Zogopoulos Geor |
KRAS variant allele frequency, but not mutation positivity, associates with survival of patients with pancreatic cancer. Cancer science 2022 May . Suzuki Tatsunori, Masugi Yohei, Inoue Yosuke, Hamada Tsuyoshi, Tanaka Mariko, Takamatsu Manabu, Arita Junichi, Kato Tomotaka, Kawaguchi Yoshikuni, Kunita Akiko, Nakai Yousuke, Nakano Yutaka, Ono Yoshihiro, Sasahira Naoki, Takeda Tsuyoshi, Tateishi Keisuke, Uemura Sho, Koike Kazuhiko, Ushiku Tetsuo, Takeuchi Kengo, Sakamoto Michiie, Hasegawa Kiyoshi, Kitago Minoru, Takahashi Yu, Fujishiro Mitsuhiro, |
Prognostic Value of Drug Targets Predicted Using Deep Bioinformatic Analysis of m6A-Associated lncRNA-Based Pancreatic Cancer Model Characteristics and Its Tumour Microenvironment. Frontiers in genetics 2022 5 13 853471. Cao Peng-Wei, Liu Lei, Li Zi-Han, Cao Feng, Liu Fu-B |
Diagnostic and Prognostic Values of KRAS Mutations on EUS-FNA Specimens and Circulating Tumor DNA in Patients With Pancreatic Cancer. Clinical and translational gastroenterology 2022 3 13 (5): e00487. Wang Ronghua, Zhao Yuchong, Wang Yun, Zhao Zhenxiong, Chen Qian, Duan Yaqi, Xiong Si, Luan Zhou, Wang Jinlin, Cheng B |
KRAS mutation allele frequency threshold alters prognosis in right-sided resected pancreatic cancer. Journal of surgical oncology 2022 3 126 (2): 314-321. Nauheim David, Moskal David, Renslo Bryan, Chadwick Matthew, Jiang Wei, Yeo Charles J, Nevler Avinoam, Bowne Wilbur, Lavu Hari |
Characterization of the genomic landscape in large-scale Chinese patients with pancreatic cancer. EBioMedicine 2022 3 77 103897. Zhang Xiaofei, Mao Tiebo, Zhang Bei, Xu Haiyan, Cui Jiujie, Jiao Feng, Chen Dongqin, Wang Yu, Hu Jiong, Xia Qing, Ge Weiyu, Li Shumin, Yue Ming, Ma Jingyu, Yao Jiayu, Wang Yongchao, Wang Yanling, Shentu Daiyuan, Zhang Xiao, Chen Shiqing, Bai Yuezong, Wang Yuexiang, Zhang Xuebin, Liu Qiang, Sun Yongwei, Fu Deliang, Liu Yingbin, Xiong Lei, Wang Liw |
The genetic landscape of pancreatic head ductal adenocarcinoma in China and prognosis stratification. BMC cancer 2022 Feb 22 (1): 186. Yang Yefan, Ding Ying, Gong Yuxi, Zhao Sha, Li Mingna, Li Xiao, Song Guoxin, Zhai Boya, Liu Jin, Shao Yang, Zhu Liuqing, Pang Jiaohui, Ma Yutong, Ou Qiuxiang, Wu Xue, Zhang Zhiho |
Kras Gene Analysis Using Liquid-Based Cytology Specimens Predicts Therapeutic Responses and Prognosis in Patients with Pancreatic Cancer. Cancers 2022 2 14 (3): . Itonaga Masahiro, Ashida Reiko, Murata Shin-Ichi, Yamashita Yasunobu, Hatamaru Keiichi, Tamura Takashi, Kawaji Yuki, Kayama Yuudai, Emori Tomoya, Kawai Manabu, Yamaue Hiroki, Matsuzaki Ibu, Nagai Hirokazu, Kinoshita Yuichi, Wan Ke, Shimokawa Toshio, Kitano Masayu |
Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant chemotherapy and stereotactic body radiotherapy followed by surgical resection. Radiation oncology journal 2022 1 39 (4): 304-314. Reddy Abhinav V, Hill Colin S, Sehgal Shuchi, Ding Ding, Hacker-Prietz Amy, He Jin, Zheng Lei, Herman Joseph M, Meyer Jeffrey, Narang Amol |
Genomic landscape of pancreatic cancer in the Japanese version of the Cancer Genome Atlas. Annals of gastroenterological surgery 2023 5 7 (3): 491-502. Taisuke Imamura, Ryo Ashida, Keiichi Ohshima, Katsuhiko Uesaka, Teiichi Sugiura, Yukiyasu Okamura, Katsuhisa Ohgi, Sumiko Ohnami, Takeshi Nagashima, Ken Yamaguc |
Analysis of Plasma Circulating Tumor DNA in Borderline Resectable Pancreatic Cancer Treated with Neoadjuvant Modified FOLFIRINOX: Clinical Relevance of DNA Damage Repair Gene Alteration Detection. Cancer research and treatment 2023 5 . Dong-Hoon Lim, Hyunseok Yoon, Kyu-Pyo Kim, Baek-Yeol Ryoo, Sang Soo Lee, Do Hyun Park, Tae Jun Song, Dae Wook Hwang, Jae Hoon Lee, Ki Byung Song, Song Cheol Kim, Seung-Mo Hong, Jaewon Hyung, Changhoon Y |
Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan. Journal of gastroenterology 2023 4 . Sakakida Tomoki, Ishikawa Takeshi, Doi Toshifumi, Morita Ryuichi, Kataoka Seita, Miyake Hayato, Yamaguchi Kanji, Moriguchi Michihisa, Sogame Yoshio, Yasuda Hiroaki, Iwasaku Masahiro, Konishi Hideyuki, Takayama Koichi, Itoh Yoshi |
Advanced pancreatic cancer with KRAS wild-type and EGFR-sensitive mutation respond favorably to furmonertinib: A case report. Frontiers in oncology 2023 4 13 1151178. Xiaoting Ma, Xiu Liu, Kai Ou, Manman Zhang, Lizhen Gao, Lin Ya |
Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implications. Cancer medicine 2023 3 . Zhao Zhiming, Li Xiaomo, Wang Fei, Xu Yong, Liu Si, Han Quanli, Yang Zhiying, Huang Weiwei, Yin Zhuzeng, Liu Qu, Tan Haidong, Ma Tonghui, Si Shuang, Huang Jia, Yuan Hongling, Li Wei, Liu Ro |
Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal Adenocarcinoma. Cancer research communications 2023 3 2 (11): 1418-1425. Christenson Eric S, Lim Su Jin, Durham Jennifer, De Jesus-Acosta Ana, Bever Katherine, Laheru Daniel, Ryan Amy, Agarwal Parul, Scharpf Robert B, Le Dung T, Wang H |
Adenosquamous carcinoma coexisting with intraductal papillary mucinous neoplasm of the pancreas: a case report. Journal of medical case reports 2023 3 17 (1): 72. Sawai Hirozumi, Kiriyama Yuka, Kuzuya Hiromasa, Fujii Yoshiaki, Ueno Shuhei, Koide Shuji, Kurimoto Masaaki, Yamao Kenji, Matsuo Yoichi, Morimoto Mamoru, Koide Hajime, Kamiya Atsus |
Novel mutant KRAS addiction signature predicts response to the combination of ERBB and MEK inhibitors in lung and pancreatic cancers. iScience 2023 2 26 (3): 106082. Tyc Katarzyna M, Kazi Aslamuzzaman, Ranjan Alok, Wang Rui, Sebti Said |
Efficient and accurate KRAS genotyping using digital PCR combined with melting curve analysis for ctDNA from pancreatic cancer patients. Scientific reports 2023 2 13 (1): 3039. Tanaka Junko, Nakagawa Tatsuo, Harada Kunio, Morizane Chigusa, Tanaka Hidenori, Shiba Satoshi, Ohba Akihiro, Hijioka Susumu, Takai Erina, Yachida Shinichi, Kamura Yoshio, Ishida Takeshi, Yokoi Takahide, Uematsu Chihi |
Utility of Comprehensive Genomic Profiling Tests for Patients with Incurable Pancreatic Cancer in Clinical Practice. Cancers 2023 2 15 (3): . Yamai Takuo, Ikezawa Kenji, Sugimoto Naotoshi, Urabe Makiko, Kai Yugo, Takada Ryoji, Nakabori Tasuku, Uehara Hiroyuki, Kawamura Takahisa, Kunimasa Kei, Yamamoto Sachiko, Wakamatsu Toru, Hayashi Takuji, Kukita Yoji, Fujisawa Fumie, Inoue Tazuko, Yamaguchi Yuko, Yamasaki Tomoyuki, Honma Keiichiro, Ohkawa Kazuyos |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: